Search research articles
Contact Us
Filters
Showing results (41-50 of 466) with videos related to
Page
of 47
Sort By:
The Lancet. Gastroenterology & Hepatology
|
January 14, 2021
Identifying the lower age limit for hepatitis C screening in large elimination programmes in highly endemic areas
Saeed Hamid, Adeel Abid, Gregory J Dore
Journal of Hepatology
|
July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic review
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Journal of Gastroenterology and Hepatology
|
December 22, 2004
Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children
Sanguansak Rerksuppaphol, Winita Hardikar, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2005
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
Anna Doab, Carla Treloar, Gregory J Dore
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C
Gregory J Dore, Heather Valerio, Jason Grebely
Nature Reviews. Gastroenterology & Hepatology
|
July 3, 2013
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Journal of Hepatology
|
November 1, 2019
Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis"
Maryam Alavi, Matthew G Law, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 23, 2015
Rely to Vogel et al
Gail V Matthews, Margaret Hellard, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology
|
March 23, 2011
Treatment of acute HCV infection
Jason Grebely, Gail V Matthews, Gregory J Dore
Journal of Hepatology
|
August 8, 2009
HCV reinfection studies and the door to vaccine development
Jason Grebely, David L Thomas, Gregory J Dore
Page
of 47
Search research articles
Search
Showing results (41-50 of 466) with videos related to
Sort By:
Page
of 47
The Lancet. Gastroenterology & Hepatology
|
January 14, 2021
Identifying the lower age limit for hepatitis C screening in large elimination programmes in highly endemic areas
Saeed Hamid, Adeel Abid, Gregory J Dore
Journal of Hepatology
|
July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic review
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Journal of Gastroenterology and Hepatology
|
December 22, 2004
Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children
Sanguansak Rerksuppaphol, Winita Hardikar, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 16, 2005
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
Anna Doab, Carla Treloar, Gregory J Dore
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C
Gregory J Dore, Heather Valerio, Jason Grebely
Nature Reviews. Gastroenterology & Hepatology
|
July 3, 2013
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Journal of Hepatology
|
November 1, 2019
Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis"
Maryam Alavi, Matthew G Law, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 23, 2015
Rely to Vogel et al
Gail V Matthews, Margaret Hellard, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology
|
March 23, 2011
Treatment of acute HCV infection
Jason Grebely, Gail V Matthews, Gregory J Dore
Journal of Hepatology
|
August 8, 2009
HCV reinfection studies and the door to vaccine development
Jason Grebely, David L Thomas, Gregory J Dore
Page
of 47